CSA Medical to be manufactured<br>from Solectron`s US plant

Following eight years of invention, testing, product development and clinical trials, CSA Medical's CryoSpray Ablation system is rolling off the assembly line at Solectron's Charlotte, N.C. manufacturing facility. CSA Medical developed the CryoSpray Ablation system, which freezes and destroys unwanted tissues found in the esophagus, which, according to various reports arises from chronic acid reflux. Solectron's integrated supply chain services and medical manufacturing capabilities enable CSA Medical to accelerate time-to-market without making costly infrastructure investments. In addition to manufacturing the CryoSpray Ablation system, Solectron manages orders and ships directly to CSA Medical customers. CSA Medical and Solectron have worked together since August 2006 to establish an optimized Lean supply chain and manufacturing process.